ARCHIVES

FDA Designates Zometa For Priority Review.

This article is from The Cancer Letter archive.

Vol. 27 No. 44 | November 30, 2001

Download PDF Visit The Full Archive

Related Articles

In Brief: Ross Retires From Bristol-Myers, Forms Own Consulting Service; Obey Wins Key Post

April 1, 1994

Tempero, Johnson Take ASCO Offices

June 6, 2003

In Brief: Robert Weinberg to Receive Bristol-Myers Award; Leffall Chosen for Poster Series

April 13, 1984

Leukemia Society Accepting Grant Applications for ‘88

May 22, 1987

Foon Moves To UPCI

April 18, 2003

The Clinical Cancer Letter To End Print Edition In 2010

November 27, 2009